YungShin Global Holding Corp (TW:3705) — Market Cap & Net Worth
Market Cap & Net Worth: YungShin Global Holding Corp (3705)
YungShin Global Holding Corp (TW:3705) has a market capitalization of $451.49 Million (NT$14.33 Billion) as of August 4, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #12628 globally and #460 in its home market, demonstrating a -0.92% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying YungShin Global Holding Corp's stock price NT$53.80 by its total outstanding shares 266365000 (266.37 Million). See YungShin Global Holding Corp capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
YungShin Global Holding Corp Market Cap History: 2015 to 2026
YungShin Global Holding Corp's market capitalization history from 2015 to 2026. Data shows growth from $259.57 Million to $451.49 Million (5.50% CAGR).
YungShin Global Holding Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how YungShin Global Holding Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
YungShin Global Holding Corp's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.54x
YungShin Global Holding Corp's market cap is 0.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $258.86 Million | $6.19 Billion | $657.99 Million | 0.04x | 0.39x |
| 2017 | $234.42 Million | $6.62 Billion | $514.06 Million | 0.04x | 0.46x |
| 2018 | $241.83 Million | $7.51 Billion | $701.98 Million | 0.03x | 0.34x |
| 2019 | $277.12 Million | $8.19 Billion | $748.60 Million | 0.03x | 0.37x |
| 2020 | $302.23 Million | $8.08 Billion | $791.72 Million | 0.04x | 0.38x |
| 2021 | $304.14 Million | $7.81 Billion | $736.62 Million | 0.04x | 0.41x |
| 2022 | $386.03 Million | $7.31 Billion | $839.03 Million | 0.05x | 0.46x |
| 2023 | $390.23 Million | $7.03 Billion | $827.30 Million | 0.06x | 0.47x |
| 2024 | $452.33 Million | $8.03 Billion | $1.17 Billion | 0.06x | 0.39x |
| 2025 | $478.34 Million | $8.38 Billion | $880.82 Million | 0.06x | 0.54x |
Competitor Companies of 3705 by Market Capitalization
Companies near YungShin Global Holding Corp in the global market cap rankings as of August 4, 2026.
Key companies related to YungShin Global Holding Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
YungShin Global Holding Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, YungShin Global Holding Corp's market cap moved from $259.57 Million to $ 451.49 Million, with a yearly change of 5.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$451.49 Million | -5.61% |
| 2025 | NT$478.34 Million | +5.75% |
| 2024 | NT$452.33 Million | +15.91% |
| 2023 | NT$390.23 Million | +1.09% |
| 2022 | NT$386.03 Million | +26.92% |
| 2021 | NT$304.14 Million | +0.63% |
| 2020 | NT$302.23 Million | +9.06% |
| 2019 | NT$277.12 Million | +14.59% |
| 2018 | NT$241.83 Million | +3.16% |
| 2017 | NT$234.42 Million | -9.44% |
| 2016 | NT$258.86 Million | -0.27% |
| 2015 | NT$259.57 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of YungShin Global Holding Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $451.49 Million USD |
| MoneyControl | $451.49 Million USD |
| MarketWatch | $451.49 Million USD |
| marketcap.company | $451.49 Million USD |
| Reuters | $451.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, an… Read more